Related Experiment Videos
A proposed staging system for primary gastric lymphoma
M Shimodaira1, Y Tsukamoto, Y Niwa
1Second Department of Internal Medicine, Nagoya University School of Medicine, Japan.
Cancer
|June 1, 1994
Summary
A new staging system for primary gastric lymphoma improves prognosis assessment. This system aids in treatment planning for this common extranodal lymphoma, showing decreased survival with advanced stages.
Area of Science:
- Oncology
- Gastroenterology
- Hematology
Background:
- Primary gastric lymphoma is the most common extranodal lymphoma.
- Currently, no specific staging system exists for primary gastric lymphoma.
- Accurate staging is crucial for prognosis and treatment planning.
Purpose of the Study:
- To develop and validate a new staging system for primary gastric lymphoma.
- To correlate tumor stage with patient survival rates.
- To provide a tool for better therapeutic decision-making.
Main Methods:
- Review of 98 primary gastric lymphoma cases classified by the Working Formulation.
- Application of the International Union Against Cancer TNM system criteria (T, N, M).
- Survival analysis using the Kaplan-Meier method.
Main Results:
- Overall 5-year survival rate was 83.5%.
- Survival rates significantly decreased with advanced T, N, and M categories.
- Proposed new staging system (Stages I-IV) showed a clear survival gradient (100% in Stage I to 25% in Stage IV).
Conclusions:
- The newly proposed staging system is effective for assessing prognosis in primary gastric lymphoma.
- This system can guide therapeutic strategies.
- Treatment decisions, particularly regarding surgery and chemotherapy, can be informed by this staging system.